comprehensive -WSS

comprehensive

author：comprehensive 2025-09-14 21:59:48 - browse：6

In a dark grey suit and light blue button-down shirt, Bill Sibold, CEO of Madrigal Pharmaceuticals, smiles— coverage from STAT — Madrigal CEO Bill Sibold says the company is "interested in the patients who are most in need." Madrigal Pharmaceuticals

The Food and Drug Administration is expected to approve the first medicine developed specifically to treat the serious liver disease known as MASH as soon as this week.

The pill, called resmetirom, is made by Madrigal Pharmaceuticals.

Metabolic dysfunction-associated steatohepatitis, or MASH and previously called NASH, is often associated with obesity. The accumulation of fat in the liver causes inflammation, which leads to fibrosis, or liver scarring, and can progress in more advanced stages to cirrhosis, cancer, and the need for a liver transplant.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Palantir health business leans on meeting customers’ needs

WSS

STAT Summit: How researchers deal with rejection

Charles Manson follower Leslie Van Houten released from prison after 53 years

Beach reads and more: STAT's 2023 summer book list

Biden launches a new push to limit health care costs

NIH fellows want a pay raise. Will that mean less money for grants?

UnitedHealth, Optum discontinue NaviHealth name

leisure time

comprehensive

focus

Wildfire smoke exposes gaps in outdoor worker protections

STAT Readout: Friday, Oct. 20 biotech updates

In Memoriam: Notable people who died in 2023

Why ADHD is under

Guidelines to prevent youth baseball injuries need more muscle

Study on Amgen’s bispecific immunotherapy produces positive data

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Iowa House, Senate pass 6

23andMe had bad news about my health. I wish a person had delivered it

Health tech investors get more selective as pandemic boom fades

explore

STAT Summit: The economic case for universal basic health care

Questions loom on AstraZeneca cancer drug as safety concerns ebb

Leqembi, other new Alzheimer’s drugs require better biomarkers

Why ADHD is under

What to know about OceanGate, the company behind the missing Titanic submersible

DOJ reversal could clear way for Carroll's 1st lawsuit against Trump to proceed

entertainment

hotspot

Wikipedia

entertainment